Artizan Biosciences Announces Corporate Progress and Financing
Finalized Series A funding, bringing total raised to date to $12MM to support proprietary platform that enables identification of disease-driving bacteria and development of therapies for inflammatory diseases Appointed Paul Miller, PhD, as Chief …